| |
| |
|
| Insider
Information: |
Mccamish Mark Anthony |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
75,165 |
|
|
Indirect Shares
|
67,025 |
|
|
| Direct
Value |
$134,453 |
|
|
|
Indirect Value
|
$1,071,730 |
|
|
| Total
Shares |
142,190 |
|
|
| Total
Value |
$1,206,182 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
2
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 36.5%
|
11.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
SVP & CMO |
2008-12-18 |
14,924 |
2007-02-21 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Director |
2020-09-16 |
0 |
2023-12-28 |
67,025 |
Premium* |
|
|
Rafael Holdings Inc |
RFL |
Director |
2024-01-05 |
60,241 |
2022-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RFL |
Rafael Holdings Inc |
Director |
– • – |
2024-01-05 |
4 |
A |
$1.81 |
$50,056 |
D/D |
27,655 |
60,241 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2023-12-28 |
4 |
AS |
$14.53 |
$1,089,750 |
I/I |
(75,000) |
67,025 |
0 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2023-08-11 |
4 |
S |
$14.93 |
$432,614 |
I/I |
(28,975) |
142,025 |
0 |
% |
|
| RFL |
Rafael Holdings Inc |
Director |
– • – |
2023-01-05 |
4 |
A |
$1.84 |
$50,000 |
D/D |
27,174 |
32,586 |
0 |
- |
|
| RFL |
Rafael Holdings Inc |
Director |
– • – |
2022-01-05 |
4 |
A |
$5.39 |
$29,171 |
D/D |
5,412 |
5,412 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2020-09-17 |
4 |
B |
$5.83 |
$305,250 |
I/I |
52,398 |
171,000 |
2.1 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2020-09-16 |
4 |
B |
$5.73 |
$679,969 |
I/I |
118,602 |
118,602 |
2.1 |
% |
|
| PDLI |
PDL Biopharma Inc |
SVP & CMO |
• – – |
2008-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,575) |
14,924 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
SVP & CMO |
• – – |
2008-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,862 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
SVP & CMO |
• – – |
2007-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
